Serotonergic modulation of the states of vigilance
|Abstract:||The serotonin (5-HT) is a neuromodulator that plays a critical role in the regulation of states of vigilance. The disbalance in the levels of serotonin is implicated in the etiology of psychiatric disorders, particularly in bipolar disorder and major depressive disorder, that are also accompanied by sleep disturbances. Based on this, we hypothesized that a reduction in serotonin levels should lead to disruptions in the sleep-wake cycle in mice. To test this hypothesis, we used TPH-2 knock-in homozygote (HO) mice that produce 20% of normal level of serotonin (Beaulieu et al., 2008) and wild-type (WT) mice with normal serotonin level. In both of those groups, we conducted chronic electrophysiological recordings of the brain activity in three (prelimbic, motor, retrosplenial) cortical areas and in the hippocampus in addition to a neck EMG. The states of vigilance were detected, the number and duration of each sleep and wake episode was measured in addition to values of Delta power. We found that the reduction in serotonin levels leads to longer duration and decreased number of individual sleep and wake episodes. HO mice displayed longer continuous sleep (combining slow-wave sleep and REM sleep) and longer wake episodes as compared to WT. We also evaluated the slow-wave activity power in all investigated cortical areas and our study reveal that depletion in serotonin leads to higher values of Delta Power. We conclude that the decrease in serotonin levels cause more consolidated states of vigilance in addition to a reduced number of episodes compared to WT. Our results surprisingly indicate that serotonin significantly influence the cortical slow-wave activity power by increasing Delta power. Our results also suggest that humans and mice differently respond to a reduction in serotonin level.|
|Document Type:||Mémoire de maîtrise|
|Open Access Date:||24 April 2019|
|Collection:||Thèses et mémoires|
All documents in CorpusUL are protected by Copyright Act of Canada.